|
⚲
|
| Keyboard |
| Draghia-Akli Ruxandra
✚
|
|
|---|---|
| CIK # | 0002041719 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0002041719] | |
| 4 | [0002041719] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Draghia-Akli Ruxandra | |
| Novavax Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Novavax Inc NVAX
Restricted Stock Units · derivative
|
2026-03-03 | Disposed to issuer | 26,667 | $0.00 | |
|
Novavax Inc NVAX
Common Stock
|
2026-03-03 | Option exercise | 26,667 | $0.00 | |
|
Novavax Inc NVAX
Common Stock
|
2026-03-03 | Tax withheld | 11,313 | $9.49 | 107,360 |
|
Novavax Inc NVAX
Non-Statutory Stock Opotion NQ · derivative
|
2026-03-02 | Grant | 139,500 | $9.09 | 1,268,055 |
|
Novavax Inc NVAX
Restricted Stock Units · derivative
|
2026-03-02 | Grant | 93,000 | $0.00 | |
|
Novavax Inc NVAX
Common Stock
|
2025-11-11 | Tax withheld | 6,048 | $7.40 | 44,755 |
|
Novavax Inc NVAX
Common Stock
|
2025-11-11 | Option exercise | 14,257 | $0.00 | |
|
Novavax Inc NVAX
Restricted Stock Units · derivative
|
2025-11-11 | Disposed to issuer | 14,257 | $0.00 | |
|
Novavax Inc NVAX
2025 Restricted Stock Units RSU · derivative
|
2025-03-03 | Grant | 80,000 | $0.00 | |
|
Novavax Inc NVAX
2025 Non-statutory Stock Option NQ · derivative
|
2025-03-03 | Grant | 120,000 | $7.87 | 944,400 |
|
Novavax Inc NVAX
Restricted Stock Units · derivative
|
2024-11-11 | Grant | 42,770 | $0.00 | |
|
Novavax Inc NVAX
Stock Option (Right to Buy) · derivative
|
2024-11-11 | Grant | 64,150 | $9.01 | 577,992 |